Display options
Share it on

JMIR Ment Health. 2016 Sep 29;3(3):e47. doi: 10.2196/mental.6001.

Web-Based Intervention to Reduce Substance Abuse and Depressive Symptoms in Mexico: Development and Usability Test.

JMIR mental health

Marcela Tiburcio, Ma Asunción Lara, Araceli Aguilar Abrego, Morise Fernández, Nora Martínez Vélez, Alejandro Sánchez

Affiliations

  1. Ramón de la Fuente Muñiz, National Institute of Psychiatry, Department of Social Sciences in Health, Direction of Epidemiological and Psychosocial Research, Mexico City, Mexico. [email protected].

PMID: 27687965 PMCID: PMC5051776 DOI: 10.2196/mental.6001

Abstract

BACKGROUND: The development of Web-based interventions for substance abuse in Latin America is a new field of interest with great potential for expansion to other Spanish-speaking countries.

OBJECTIVE: This paper describes a project aimed to develop and evaluate the usability of the Web-based Help Program for Drug Abuse and Depression (Programa de Ayuda para Abuso de Drogas y Depresión, PAADD, in Spanish) and also to construct a systematic frame of reference for the development of future Web-based programs.

METHODS: The PAADD aims to reduce substance use and depressive symptoms with cognitive behavioral techniques translated into Web applications, aided by the participation of a counselor to provide support and guidance. This Web-based intervention includes 4 steps: (1) My Starting Point, (2) Where Do I Want to Be? (3) Strategies for Change, and (4) Maintaining Change. The development of the program was an interactive multistage process. The first stage defined the core structure and contents, which were validated in stage 2 by a group of 8 experts in addiction treatment. Programming of the applications took place in stage 3, taking into account 3 types of end users: administrators, counselors, and substance users. Stage 4 consisted of functionality testing. In stage 5, a total of 9 health professionals and 20 drug users currently in treatment voluntarily interacted with the program in a usability test, providing feedback about adjustments needed to improve users' experience.

RESULTS: The main finding of stage 2 was the consensus of the health professionals about the cognitive behavioral strategies and techniques included in PAADD being appropriate for changing substance use behaviors. In stage 5, the health professionals found the functionalities easy to learn; their suggestions were related to the page layout, inclusion of confirmation messages at the end of activities, avoiding "read more" links, and providing feedback about every activity. On the other hand, the users said the information presented within the modules was easy to follow and suggested more dynamic features with concrete instructions and feedback.

CONCLUSIONS: The resulting Web-based program may have advantages over traditional face-to-face therapies owing to its low cost, wide accessibility, anonymity, and independence of time and distance factors. The detailed description of the process of designing a Web-based program is an important contribution to others interested in this field. The potential benefits must be verified in specific studies.

TRIAL REGISTRATION: International Standard Randomized Controlled Trial Number (ISRCTN): 25429892; http://www.controlled-trials.com/ISRCTN25429892 (Archived by WebCite at http://www.webcitation.org/6ko1Fsvym).

Keywords: Internet; cognitive behavioral therapy; depressive symptoms; substance abuse; usability

Conflict of interest statement

Conflicts of Interest: None declared.

References

  1. J Consult Clin Psychol. 1999 Aug;67(4):563-70 - PubMed
  2. Telemed J E Health. 2000 Winter;6(4):401-7 - PubMed
  3. J Gen Intern Med. 2001 Sep;16(9):606-13 - PubMed
  4. Ethics Behav. 2003;13(3):211-9 - PubMed
  5. Arch Gen Psychiatry. 2004 Mar;61(3):264-72 - PubMed
  6. J Subst Abuse Treat. 2004 Mar;26(2):109-16 - PubMed
  7. J Am Med Inform Assoc. 2004 Jul-Aug;11(4):235-40 - PubMed
  8. Br J Psychiatry. 2004 Jul;185:46-54 - PubMed
  9. Addiction. 2004 Nov;99(11):1410-7 - PubMed
  10. J Am Coll Health. 2005 May-Jun;53(6):263-74 - PubMed
  11. Am J Psychiatry. 2005 Aug;162(8):1452-60 - PubMed
  12. Behav Res Ther. 2005 Oct;43(10):1321-33 - PubMed
  13. Tob Control. 2006 Feb;15(1):7-12 - PubMed
  14. Behav Ther. 2006 Jun;37(2):190-205 - PubMed
  15. Psychol Med. 2007 Mar;37(3):319-28 - PubMed
  16. Med J Aust. 2007 Oct 1;187(7 Suppl):S35-9 - PubMed
  17. Addiction. 2008 Feb;103(2):218-27 - PubMed
  18. J Public Health (Oxf). 2008 Mar;30(1):103-9 - PubMed
  19. Am J Psychiatry. 2008 Jul;165(7):881-8 - PubMed
  20. Adolesc Med State Art Rev. 2007 Aug;18(2):342-56, xii - PubMed
  21. Drug Alcohol Depend. 2009 Feb 1;100(1-2):178-81 - PubMed
  22. Arch Intern Med. 2009 May 25;169(10):929-37 - PubMed
  23. Health Promot Pract. 2011 Mar;12(2):193-201 - PubMed
  24. Clin Psychol Rev. 2011 Apr;31(3):490-8 - PubMed
  25. Med J Aust. 2011 Aug 1;195(3):S44-50 - PubMed
  26. Psychol Health Med. 2013;18(2):155-65 - PubMed
  27. BMC Public Health. 2012 Sep 26;12:826 - PubMed
  28. BMC Med Inform Decis Mak. 2013 Feb 20;13:26 - PubMed
  29. JMIR Res Protoc. 2013 Jan 23;2(1):e6 - PubMed
  30. Rev Panam Salud Publica. 2014 May-Jun;35(5-6):399-406 - PubMed
  31. BMC Med Inform Decis Mak. 2015 Jul 28;15:57 - PubMed
  32. J Med Internet Res. 2015 Oct 13;17(10):e232 - PubMed
  33. JMIR Ment Health. 2016 Jan 06;3(1):e1 - PubMed
  34. Internet Interv. 2015 Sep;2(3):303-313 - PubMed
  35. Addict Behav. 1998 Nov-Dec;23(6):893-907 - PubMed

Publication Types